FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Jan 2002. Module: SNOMED CT model component

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Case sensitive SNOMED CT model component
900000000001157018 REPLACED BY association reference set en Synonym Active Case sensitive SNOMED CT model component

131244 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set Is a Historical association true Inferred relationship Some
Members associationTargetComponent
Adesan (candesartan cilexetil 8 mg) uncoated tablet, 30 tablets (trade product pack) Unknown Cell Type 2
Adesan (candesartan cilexetil 8 mg) uncoated tablet, 30 tablets, blister pack (containered trade product pack) Unknown Cell Type 2
Adesan (candesartan cilexetil 8 mg) uncoated tablet, 30 tablets, bottle (containered trade product pack) Unknown Cell Type 2
Adesan 16 mg uncoated tablet Unknown Cell Type 2
Adesan 16 mg uncoated tablet, 30 Unknown Cell Type 2
Adesan 16 mg uncoated tablet, 30, blister pack Unknown Cell Type 2
Adesan 16 mg uncoated tablet, 30, bottle Unknown Cell Type 2
Adesan 32 mg uncoated tablet Unknown Cell Type 2
Adesan 32 mg uncoated tablet, 30 Unknown Cell Type 2
Adesan 32 mg uncoated tablet, 30, blister pack Unknown Cell Type 2
Adesan 32 mg uncoated tablet, 30, bottle Unknown Cell Type 2
Adesan 4 mg uncoated tablet Unknown Cell Type 2
Adesan 4 mg uncoated tablet, 30 Unknown Cell Type 2
Adesan 4 mg uncoated tablet, 30, blister pack Unknown Cell Type 2
Adesan 4 mg uncoated tablet, 30, bottle Unknown Cell Type 2
Adesan 8 mg uncoated tablet Unknown Cell Type 2
Adesan 8 mg uncoated tablet, 30 Unknown Cell Type 2
Adesan 8 mg uncoated tablet, 30, blister pack Unknown Cell Type 2
Adesan 8 mg uncoated tablet, 30, bottle Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet (trade product unit of use) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 28 tablets (trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 28 tablets, blister pack (containered trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 30 tablets (trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 30 tablets, blister pack (containered trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 30 tablets, bottle (containered trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 7 tablets (trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 (candesartan cilexetil 16 mg + hydrochlorothiazide 12.5 mg) uncoated tablet, 7 tablets, blister pack (containered trade product pack) Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 28 Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 28, blister pack Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 30 Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 30, blister pack Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 30, bottle Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 7 Unknown Cell Type 2
Adesan HCT 16/12.5 uncoated tablet, 7, blister pack Unknown Cell Type 2
Adhesiolysis - action Dissection - action
Adhesive sealing Sealing
Adie's pupil Tonic pupillary reaction
Adin (desmopressin acetate 100 microgram) uncoated tablet (trade product unit of use) Unknown Cell Type 2
Adin (desmopressin acetate 100 microgram) uncoated tablet, 30 tablets (trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 100 microgram) uncoated tablet, 30 tablets, bottle (containered trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 100 microgram) uncoated tablet, 7 tablets (trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 100 microgram) uncoated tablet, 7 tablets, bottle (containered trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 200 microgram) uncoated tablet (trade product unit of use) Unknown Cell Type 2
Adin (desmopressin acetate 200 microgram) uncoated tablet, 30 tablets (trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 200 microgram) uncoated tablet, 30 tablets, bottle (containered trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 200 microgram) uncoated tablet, 7 tablets (trade product pack) Unknown Cell Type 2
Adin (desmopressin acetate 200 microgram) uncoated tablet, 7 tablets, bottle (containered trade product pack) Unknown Cell Type 2
Adin 100 microgram uncoated tablet Unknown Cell Type 2
Adin 100 microgram uncoated tablet, 30 Unknown Cell Type 2
Adin 100 microgram uncoated tablet, 30, bottle Unknown Cell Type 2
Adin 100 microgram uncoated tablet, 7 Unknown Cell Type 2
Adin 100 microgram uncoated tablet, 7, bottle Unknown Cell Type 2
Adin 200 microgram uncoated tablet Unknown Cell Type 2
Adin 200 microgram uncoated tablet, 30 Unknown Cell Type 2
Adin 200 microgram uncoated tablet, 30, bottle Unknown Cell Type 2
Adin 200 microgram uncoated tablet, 7 Unknown Cell Type 2
Adin 200 microgram uncoated tablet, 7, bottle Unknown Cell Type 2
Adjustment of external splintage Adjusting of splint
Adjustment reaction in infancy Adjustment reaction in infancy
Adjustment reaction of adolescence Adjustment reaction of adolescence
Adjustment reaction of adult life Adjustment reaction of adult life
Adjustment reaction of childhood Adjustment reaction of childhood
Adjustment reaction of late life Adjustment reaction of late life
Administration Administration of substance
Administration Administration of substance
Administration Administration of substance
Administration Administration of substance
Administration of Anti-D globulin Administration of human anti-D immunoglobulin
Administration of Anti-D refused Administration of human anti-D immunoglobulin declined
Administration of prescribed medications and solutions Administration of medicine
Administration of prescribed medicines based on arterial blood gas results Administration of medicine
Administration of skin test by nurse Skin test
Administration of syntometrine Administration of ergometrine and oxytocin
Administration of Human papillomavirus 9 vaccine Administration of Human papillomavirus 6, 11, 16, 18, 31, 33, 45, 52 and 58 vaccine
Administrative and indirect care procedures Procedure
Adrenaject Auto-Injector 150 microgram/0.3 mL injection solution, 1 dose Adrenaject Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL pen device (trade product pack)
Adrenaject Auto-Injector 150 microgram/0.3 mL injection solution, 1 dose, injection device Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL pen device
Adrenaject Auto-Injector 150 microgram/0.3 mL injection solution, 2 x 1 dose Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
Adrenaject Auto-Injector 150 microgram/0.3 mL injection solution, 2 x 1 dose, injection devices Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
Adrenaject Auto-Injector 150 microgram/0.3 mL injection solution, dose Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL pen device
Adrenaject Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 0.3 mL injection device (trade product unit of use) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (containered trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 2 x 0.3 mL injection devices (containered trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 150 microgram / 0.3 mL) injection, 2 x 0.3 mL injection devices (trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector 300 microgram/0.3 mL injection solution, 1 dose Adrenaject Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device
Adrenaject Auto-Injector 300 microgram/0.3 mL injection solution, 1 dose, injection device Adrenaject Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device
Adrenaject Auto-Injector 300 microgram/0.3 mL injection solution, 2 x 1 dose Adrenaject Auto-Injector 300 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
Adrenaject Auto-Injector 300 microgram/0.3 mL injection solution, 2 x 1 dose, injection devices Adrenaject Auto-Injector 300 microgram/0.3 mL injection, 2 x 0.3 mL pen devices
Adrenaject Auto-Injector 300 microgram/0.3 mL injection solution, dose Adrenaject Auto-Injector 300 microgram/0.3 mL injection, 0.3 mL pen device
Adrenaject Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 0.3 mL injection device (trade product unit of use) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (containered trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 1 x 0.3 mL injection device (trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 2 x 0.3 mL injection devices (containered trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector (epinephrine 300 microgram / 0.3 mL) injection, 2 x 0.3 mL injection devices (trade product pack) Unknown Cell Type 2
Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL injection device Unknown Cell Type 2
Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL injection device Unknown Cell Type 2
Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 0.3 mL injection device Unknown Cell Type 2
Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 2 x 0.3 mL injection devices Unknown Cell Type 2
Adrenaject Auto-Injector 150 microgram/0.3 mL injection, 2 x 0.3 mL injection devices Unknown Cell Type 2

Start Previous Page 25 of 1313 Next End

Reference Sets

Australian dialect reference set

Unit of use quantity reference set

Reference set descriptor

Back to Start